InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.600
-0.080 (-4.76%)
Oct 10, 2025, 2:36 PM EDT - Market open
InterCure Market Cap
InterCure has a market cap or net worth of $78.27 million as of October 10, 2025. Its market cap has decreased by -14.13% in one year.
Market Cap
78.27M
Enterprise Value
117.72M
1-Year Change
-14.13%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $78.27M, an increase of 4,294.11%. That is a compound annual growth rate of 29.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 78.27M | 4.90% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | 137.03M | 17.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |